# Targeted Deprescribing in Patients on Hemodialysis

> **NCT03733262** · — · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 480 (estimated)

## Conditions studied

- End Stage Renal Disease on Dialysis (Diagnosis)

## Interventions

- **OTHER:** De-prescribing Trial

## Key facts

- **NCT ID:** NCT03733262
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-03-30
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2024-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03733262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03733262, "Targeted Deprescribing in Patients on Hemodialysis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03733262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*